Compare TCBK & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TCBK | ALVO |
|---|---|---|
| Founded | 1975 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | N/A | N/A |
| Metric | TCBK | ALVO |
|---|---|---|
| Price | $47.32 | $5.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $48.60 | $9.25 |
| AVG Volume (30 Days) | 138.1K | ★ 630.4K |
| Earning Date | 01-22-2026 | 11-12-2025 |
| Dividend Yield | ★ 3.04% | N/A |
| EPS Growth | ★ 5.66 | N/A |
| EPS | ★ 3.55 | 0.24 |
| Revenue | $399,268,000.00 | ★ $573,350,000.00 |
| Revenue This Year | $9.49 | $20.85 |
| Revenue Next Year | $5.50 | $44.49 |
| P/E Ratio | ★ $13.34 | $21.36 |
| Revenue Growth | 3.12 | ★ 45.55 |
| 52 Week Low | $35.20 | $4.32 |
| 52 Week High | $50.61 | $13.70 |
| Indicator | TCBK | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 43.73 | 47.00 |
| Support Level | $48.97 | $4.79 |
| Resistance Level | $50.61 | $5.35 |
| Average True Range (ATR) | 0.85 | 0.30 |
| MACD | -0.42 | 0.05 |
| Stochastic Oscillator | 13.52 | 40.68 |
TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.